mPEG amide acetaldehyde - MW 5000 Da

Cat. No.: M163978
Disponible para pedir
CALIDAD & PUREZA MW 5000 Da
Storage
Room temperature
Shipped In
Normal
★
Talla
Alemania (EU)
USA*
Precio
Cantidad
250mg
M163978-250mg
—
2 Disponible
46,77€
1g
M163978-1g
—
2 Disponible
115,32€
Enter a quantity for the sizes you want to add.

Especificaciones

Especificaciones y pureza
MW 5000 Da
Condiciones de almacenamiento de almacenamiento
Room temperature
Enviado en
Normal

Datos avanzados

Certificados (CoA, COO, BSE/TSE y tabla de análisis)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

1 results found

Lot NumberCertificate TypeFechaArticulo
D1825029D1825029Certificate of AnalysisMar 08, 2024 M163978
Preguntas frecuentes y artículos
Calculadoras de soluciones
Reseñas

Reseñas de cliente

Application Protocols
  • Note: No item-specific, validated protocols are provided in the Product Data. The following are general, literature-style example procedures to illustrate typical use.

  • Example 1: N-terminal PEGylation of a protein by reductive amination

    • Prepare protein at 2 mg/mL in 50 mM sodium acetate, pH 5.5 (avoid Tris/glycine).
    • Dissolve mPEG amide acetaldehyde in the same buffer (or ≤10% DMSO cosolvent) and add to achieve 5 equiv relative to estimated N-termini.
    • Incubate at RT for 1 h, then add NaBH3CN to 20 mM final (handle with care) and continue at RT for 4–16 h with gentle agitation.
    • Quench by buffer exchange into PBS pH 7.4 using a centrifugal filter (MWCO selected per conjugate size). Analyze by SDS-PAGE and SEC.
  • Example 2: Oxime ligation with an aminooxy-functionalized peptide

    • Dissolve peptide (1 mM) and mPEG amide acetaldehyde (1.5 mM) in 100 mM sodium acetate, pH 5.0.
    • Add aniline catalyst to 50 mM. React at RT for 2 h.
    • Monitor by LC–MS; upon completion, purify by preparative HPLC or SEC.
  • Example 3: Surface functionalization of amine-terminated nanoparticles

    • Disperse nanoparticles in anhydrous DMF (or water if stable) and add 2–10 equiv mPEG amide acetaldehyde per surface amine.
    • Stir at RT for 2 h; add NaBH(OAc)3 (25 mM) and continue 2–12 h.
    • Work up by repeated centrifugation/washing or diafiltration. Characterize hydrodynamic size and zeta potential.
  • Tips

    • Verify aldehyde content by a small-scale titration (e.g., hydroxylamine) to set stoichiometry. Use fresh buffers and avoid amine-containing components during coupling.
Biological Roles
  • Item-specific note

    • This reagent is for research use only (per Product Data). No medical or clinical uses are claimed or supported.
  • General roles of PEG and aldehyde functionality (literature/typical)

    • PEG as a biophysical modifier: covalent attachment to biomolecules increases hydrodynamic radius, reduces nonspecific interactions, and can modulate biodistribution in research models. PEG is widely used to confer “stealth” and antifouling properties to surfaces and nanoparticles in vitro.
    • Aldehyde chemistry in bioconjugation: aldehydes react selectively with primary amines (via imines, then reductive stabilization), and with aminooxy/hydrazide groups to form oximes/hydrazones under mild, aqueous conditions. N-terminal α-amines of proteins are often more reactive at mildly acidic pH than ε-lysines, offering some selectivity.
    • Linker architecture: the amide spacer proximal to the aldehyde can influence local polarity and flexibility, affecting conjugation rates and the microenvironment around the linkage.
    • Stability considerations: oximes are generally more hydrolytically stable than hydrazones; reductive amination affords secondary amines that are robust in physiological buffers commonly used in research settings.
  • Practical implications for in vitro work

    • Choice of conjugation chemistry (reductive amination vs oxime) should consider downstream assay conditions and required linkage stability.
    • Excess reagent removal is typically achieved by size-exclusion chromatography or ultrafiltration when working with proteins and nanoparticles.
  • Documentation

    • For any biological testing, ensure removal of unreacted polymer and verify conjugation levels by orthogonal methods (SEC, SDS-PAGE, MS for peptides).
Buffer Applications
  • Applicability

    • This product is not a buffering agent. However, buffer choice is critical to its performance in conjugation reactions involving the aldehyde end-group (general guidance).
  • Buffers commonly used (literature/typical)

    • Reductive amination (protein N-termini): 50–100 mM sodium acetate, pH 5.0–6.0; optional 0.1–1 M NaCl for ionic strength; reductant such as NaBH3CN (carefully handled) or NaBH(OAc)3 added last.
    • Oxime ligation (aminooxy targets): 50–200 mM sodium acetate or citrate, pH 4.5–5.5; aniline catalyst 10–100 mM can accelerate; reactions often complete at RT in 1–4 h.
    • Hydrazone formation: similar to oxime but typically slower; can be stabilized post-formation by mild reduction.
  • Compatibility cautions

    • Avoid primary amine-containing buffers (e.g., Tris) as they compete with the intended nucleophile.
    • Phosphate buffers are acceptable for some protocols (pH ≥6), but acetate/citrate are preferred at lower pH to promote condensation.
    • Minimize metal catalysts unless required; aldehydes can undergo side reactions in the presence of certain transition metals.
  • Practical tips

    • Degas buffers if oxygen-sensitive substrates are present; aldehyde oxidation is generally slow but can occur over long times.
    • Filter-sterilize (0.22 µm) and use freshly prepared buffers to reduce background reactivity and microbial contamination in extended incubations.
Green Alternatives
  • Greener practices for using mPEG amide acetaldehyde (general guidance)

    • Prefer aqueous media: conduct oxime/hydrazone ligations in water or acetate buffer (pH 4.5–5.5), minimizing organic cosolvents.
    • Catalyst selection: aniline catalysis (10–100 mM) can accelerate oxime formation under mild, aqueous conditions, reducing time and energy input.
    • Reductant choice: sodium triacetoxyborohydride [NaBH(OAc)3] or pyridine–borane are less hazardous than NaBH3CN in some contexts; evaluate substrate compatibility and waste profiles.
    • Solvent replacement: where non-aqueous processing is required, consider 2-MeTHF or CPME instead of chlorinated solvents; confirm PEG solubility first.
    • Energy efficiency: reactions often proceed at ambient temperature; avoid unnecessary heating.
  • Comparison snapshot (literature/typical; not item-specific) | Aspect | Conventional approach | Greener alternative | |---|---|---| | Solvent | DMF/DMSO-heavy systems | Predominantly aqueous buffers; ≤10–20% co-solvent | | Reductive amination | NaBH3CN (cyanide-containing) | NaBH(OAc)3 or hydrogenation (Pd/C) in ethanol/water, if compatible | | Oxime catalysis | None or organic catalysts | Aqueous aniline catalysis at room temp | | Workup | Large solvent volumes | Ultrafiltration/diafiltration for bioconjugates; minimal organic extractions |

  • Notes

    • Always balance green metrics with product quality and target stability. Validate alternatives at small scale before process adoption.
Pharmaceutical Uses
  • Item-specific note

    • For research use only (per Product Data). No clinical or therapeutic claims are made. Pharmacopeial status for this specific item is not specified; refer to CoA/Spec Sheet.
  • General context (literature/typical for PEG functional reagents)

    • Process development: mPEG–aldehyde reagents are widely explored in research settings for developing PEGylation processes of biologics due to their chemoselective reactivity with N-termini and aminooxy/hydrazide tags.
    • Formulation/excipient role: PEG chains can enhance solubility and reduce aggregation in experimental formulations; when covalently attached, they act as polymeric linkers/spacers rather than classical excipients.
    • Manufacturing considerations: quality attributes include average molecular weight, dispersity, aldehyde functionality, residual solvents/metals, and endotoxin/bioburden levels when intended for bioprocess development.
  • Practical guidance (non-clinical)

    • If translating methods toward regulated environments, establish robust analytical controls: SEC/GPC for MW profile, NMR for end-group integrity, aldehyde titration, and residuals testing.
    • Control of process impurities (unreacted PEG, oligomers) and removal of reducing agents is essential for downstream compatibility.
  • Documentation

    • For this item, consult the CoA/Spec Sheet for any available compliance notes (e.g., low bioburden, residual solvent limits) if relevant to your research workflow.
Physical Properties
  • Item-specific (from Product Data)

    • Appearance: Not specified for this item; refer to CoA/Spec Sheet.
    • Molecular weight: Not specified for this item; refer to CoA/Spec Sheet.
  • General properties for mPEG-aldehyde polymers (literature/typical; not item-specific specs)

    • Physical state: typically white to off-white solid or waxy material; the tactile form depends on PEG MW (lower MWs can be viscous liquids; higher MWs are solids).
    • Solubility: highly soluble in water and polar protic solvents (e.g., methanol, ethanol), and in polar aprotic solvents (DMF, DMSO). Limited solubility in nonpolar solvents (hexanes, toluene). Aldehyde terminus remains reactive in aqueous media, especially at mildly acidic pH.
    • Hygroscopicity: PEG chains are hygroscopic and readily absorb moisture, which can increase aldehyde hydration (gem-diol formation) and diminish apparent reactivity.
    • Viscosity: solutions can be viscous at higher concentrations; viscosity increases with PEG molecular weight.
    • Refractive index: PEG solutions exhibit elevated refractive index versus water; absolute values depend on concentration and chain length (literature typical nD for neat PEG 400 ≈1.46 at 20 °C; for reference only).
    • Thermal behavior: PEGs have low glass transition temperatures and MW-dependent softening/melting ranges (e.g., PEG 2–5 kDa typically softens below 60 °C; literature, not item-specific). Avoid prolonged heating to preserve aldehyde integrity.
    • pKa/LogP: not applicable directly (non-ionizable polymer backbone; neutral). Aldehyde hydration is pH-dependent (favored in water, especially under acidic conditions).
  • Important note

    • Where precise numerical specifications are required (e.g., MW average, polydispersity, water content), consult the CoA/Spec Sheet for this item.
Quality and Grades
  • Item-specific (from Product Data)

    • Grade/Purity: Not specified for this item; refer to CoA/Spec Sheet.
  • Interpreting quality for mPEG functional reagents (general guidance)

    • Average molecular weight (Mn/Mw) and dispersity (Ð): critical for reproducibility in conjugation. Narrow dispersity improves batch-to-batch performance.
    • End-group fidelity: the fraction of chains bearing the intended amide–acetaldehyde terminus should be high; residual hydroxy-, carboxyl-, or degraded end-groups reduce effective functionality.
    • Residual reagents/solvents: levels of catalysts, salts, and solvents (e.g., DMF, toluene) should be controlled; low residuals are favored for sensitive bioconjugations.
    • Water content: affects aldehyde hydration and reaction rates; verify Karl Fischer where relevant. Item-specific value is not provided here.
    • Analytical confirmation: vendors commonly provide 1H NMR (end-group signals), FTIR (C=O, C–O–C), GPC/SEC (MW profile), and functional titration of aldehyde content (e.g., hydroxylamine or 2,4-DNPH assays).
  • Practical implications

    • For bioconjugation, prioritize lots with documented high aldehyde content and low dispersity. Confirm the recommended solvent system and any stabilizers if listed on the CoA.
  • Documentation

    • For this specific item, consult the CoA/Spec Sheet for: exact average MW, dispersity, assay for aldehyde functionality, residual solvents/metals, and recommended quality tests.
Reaction and Applications
  • Typical applications (literature/typical for mPEG amide acetaldehyde)

    • Site-selective PEGylation of biomolecules via:
      • Reductive amination with N-terminal α-amines of proteins/peptides at pH ~5–6 using NaBH3CN or NaBH(OAc)3.
      • Oxime ligation with aminooxy-functionalized targets (fast, catalyst-accelerated by aniline) at pH ~4.5–5.5.
      • Hydrazone formation with hydrazide-modified substrates (optionally stabilized by reduction).
    • Material/surface modification: coupling to amine-terminated polymers, resins, and nanoparticles to impart hydrophilicity and stealth behavior.
    • Ligand/display systems: attachment of PEG spacers to small molecules to improve solubility or create linkers in ADCs and affinity matrices.
  • Practical notes

    • Aldehyde hydration competes with nucleophile addition in water; mildly acidic buffers shift equilibria toward imine/oxime formation.
    • End-group access can be rate-limiting for high-MW PEGs; maintain sufficient dilution and gentle agitation to avoid gel-like microenvironments.
    • Use an excess of mPEG-aldehyde (1.2–5 equiv relative to accessible amines) to drive conversions on complex surfaces or proteins.
    • Monitor reactions by SEC (bioconjugates), MALDI-TOF (peptides), SDS-PAGE shift, or derivatization assays (e.g., hydroxylamine titration of unreacted aldehyde).
  • Manufacturer Applications

    • The catalog listing provides no specific application text for this SKU. The uses above reflect standard practice for amide-linked mPEG–acetaldehyde reagents.
  • Caution

    • Avoid strong bases and high temperatures that can promote side reactions (aldol condensations) or degrade PEG chains. Remove reducing agents thoroughly after conjugation.
Reaction Conditions
  • General conditions (literature/typical; optimize per substrate)

    • Reductive amination (proteins/peptides/small molecules):
      • Buffer: 50–100 mM sodium acetate, pH 5.0–6.0 (avoid primary amine buffers).
      • Stoichiometry: 1.5–10 equiv mPEG–aldehyde per accessible amine (protein: 2–20 mg/mL typical).
      • Reductant: NaBH3CN (5–50 mM) or NaBH(OAc)3 (10–50 mM); add last; stir/rock at 4–25 °C for 2–16 h.
      • Workup: quench, then desalt/SEC or ultrafiltration (10–100 kDa MWCO depending on PEG/protein size).
    • Oxime ligation (aminooxy targets):
      • Buffer: 100–200 mM acetate or citrate, pH 4.5–5.5.
      • Catalyst: aniline (10–100 mM) can accelerate; reaction typically 1–4 h at RT.
      • Stoichiometry: 1.2–3 equiv mPEG–aldehyde; adjust for steric crowding.
    • Hydrazone coupling (hydrazides): similar to oxime but slower; consider post-reduction with NaBH3CN to stabilize.
  • Solvent notes

    • For poorly soluble substrates, include ≤20% DMF or DMSO. Maintain oxygen exposure low when sensitive components are present. High PEG MW may require dilution to manage viscosity.
  • Monitoring and endpoints

    • SEC, SDS-PAGE shift (proteins), MALDI-TOF/ESI-MS (peptides/small molecules), or derivatization assays to confirm aldehyde consumption.
  • Yields and selectivity

    • Highly substrate-dependent; oxime ligations often reach >80% conversion under optimized conditions (literature). Reductive aminations with proteins can be N-terminus-favored at pH ~5–6 but may label lysines at higher pH.
  • Cautions

    • Avoid strong acids/bases; do not use amine-containing buffers (Tris, glycine) during coupling. Remove reducing agents thoroughly after reaction.
Safety and Handling
  • Item-specific (from Product Data)

    • GHS classification: Not specified for this item; refer to SDS.
    • Signal word / H-statements / Pictograms: Not specified for this item; refer to SDS.
    • Storage conditions: Room temperature (per Product Data). Ship at ambient conditions (Normal).
  • General safety guidance (literature/typical; not a substitute for SDS)

    • Hazards: PEG backbones are generally considered of low acute toxicity; however, aldehyde end-groups are reactive, can cause irritation to skin/eyes/respiratory tract, and may sensitise on prolonged contact. Avoid inhalation of dusts/aerosols and contact with eyes/skin.
    • PPE: wear lab coat, safety glasses, and appropriate chemical-resistant gloves (e.g., nitrile). Use in a fume hood when weighing or handling powders/solutions that may generate aerosols.
    • Handling: minimize exposure to air and moisture to limit aldehyde hydration/oxidation. Work under dry conditions when possible. Close containers promptly after use.
    • Incompatibilities: strong oxidizers (risk of aldehyde oxidation to acids), strong bases (may accelerate side reactions/aldol condensations), and strong acids (can promote acetalization/hydration). Avoid sodium hypochlorite and peroxides.
    • Stability notes: polyethers can slowly form peroxides on prolonged exposure to air/UV; although less common for solid PEGs, store away from light and heat. Aldehyde groups can oxidize; consider inert gas backfill for long-term storage.
    • First aid (overview):
      • Eye/skin: rinse cautiously with water for several minutes; remove contaminated clothing; seek medical attention if irritation persists.
      • Inhalation: move to fresh air; seek medical attention if symptoms occur.
      • Ingestion: rinse mouth; do not induce vomiting; seek medical attention.
  • Always defer to the product-specific SDS for authoritative safety information.

Solvent Selection
  • General solvent behavior (literature/typical for mPEG-aldehydes)

    • Polarity/miscibility: mPEG is amphiphilic and highly water-miscible; it also dissolves in many polar organics (MeOH, EtOH, ACN, DMF, DMSO). Solubility drops in nonpolar solvents (hexanes, cyclohexane), sometimes improved with cosolvents.
    • Dielectric environment: aldehyde–amine condensations and oxime/hydrazone ligations proceed well in aqueous buffers at mildly acidic pH. Reductive amination can be run in water, aqueous alcohols, or mixed aqueous/DMF.
    • Drying: for strictly anhydrous imine formation, use dry DMF, MeOH, or 2-MeTHF with molecular sieves; however, aminooxy/hydrazide couplings are robust in water.
  • Choosing solvents by application

    • Protein/peptide conjugation: aqueous acetate or phosphate buffers (pH 4.5–6.5) ± cosolvent (≤20% DMF or DMSO) to maintain protein solubility while preserving aldehyde reactivity.
    • Surface/nanomaterial functionalization: anhydrous DMF, DMSO, or 2-MeTHF for uniform wetting and controlled kinetics.
    • Reductive amination: water or aqueous alcohols with NaBH3CN/NaBH(OAc)3; keep ionic strength moderate to maintain solubility.
  • Brief comparison (general)

    • Water: green, biocompatible; fastest oxime/hydrazone formation at mildly acidic pH.
    • DMF/DMSO: excellent solubility; remove thoroughly post-reaction; consider toxicity and disposal.
    • Alcohols (MeOH/EtOH): good solubility, facilitate reductive amination; flammable.
    • 2-MeTHF: greener ether option for non-aqueous work; limited PEG solubility at higher MWs.
  • Item-specific note

    • No solvent specifications are provided for this item; optimize empirically for your target and consult the CoA/Spec Sheet if available.
Storage and Reconstitution
  • Item-specific (from Product Data)

    • Storage conditions: Room temperature.
    • Shipped in: Normal (ambient) conditions.
  • General best practices for this reagent class (literature/typical)

    • Storage environment: keep tightly sealed in a dry, inert atmosphere (desiccator or with desiccant). Backfill with nitrogen/argon after opening to limit aldehyde oxidation/hydration. Store away from light and heat sources.
    • Container: amber glass or other moisture-impermeable packaging recommended. Clearly label open date and lot.
    • Stability: aldehyde groups can slowly oxidize to acids over time, especially in moist air. Plan to use opened material within a reasonable timeframe; for long-term, prepare aliquots under dry conditions.
  • Reconstitution

    • Solvents: dissolve in water, aqueous acetate/citrate buffer (pH 4.5–6.0), or polar organics (DMF, DMSO, alcohols) depending on application.
    • Concentration: prepare at concentrations that avoid excessive viscosity (e.g., 1–100 mg/mL depending on PEG MW and workflow). Filter sterilize (0.22 µm) for biological work.
    • Aliquoting: prepare single-use aliquots to avoid repeated exposure to air/moisture. Freeze-thaw is generally less relevant for solids, but for solutions store at 2–8 °C (short term) or −20 °C (longer term) if compatible; avoid multiple freeze–thaw cycles.
  • Documentation

    • No stabilizers or additional storage instructions are specified for this item; refer to the CoA/Spec Sheet and SDS for any lot-specific recommendations.
Structure and Identity
  • Item-specific (from Product Data)

    • Product name: mPEG amide acetaldehyde (SKU: M163978)
    • CAS: Not specified for this item; refer to CoA/Spec Sheet.
    • Molecular formula: Not specified for this item; refer to CoA/Spec Sheet.
    • Molecular weight: Not specified for this item; refer to CoA/Spec Sheet.
    • SMILES: Not specified for this item; refer to CoA/Spec Sheet.
    • InChIKey: Not specified for this item; refer to CoA/Spec Sheet.
  • General structural description (literature/typical for this class)

    • Core motif: monomethoxy poly(ethylene glycol) (mPEG) backbone, –CH2–CH2–O– repeated n times, with a terminal methoxy cap (–OCH3) on one end.
    • Functional terminus: an amide-linked acetaldehyde handle. A common representation is mPEG–NH–C(=O)–CH2–CHO, where the PEG chain is connected to an amide spacer that bears a terminal aldehyde (acetaldehyde) group.
    • Functional groups: polyether (PEG), secondary amide, and aldehyde. The aldehyde is electrophilic and reactive toward amines, hydrazides, and aminooxy groups.
    • Topology: linear, non-ionic, highly flexible polymeric chain with a single reactive end-group; the opposite end is methoxy-capped and inert.
    • 2D description in words: a long, repeating –CH2–CH2–O– chain ending in –OCH3 on one side; the other side terminates in –NH–C(=O)–CH2–CHO, placing the aldehyde one methylene away from the amide carbonyl.
  • Notes

    • Exact PEG chain length (n), polydispersity, and end-group substitution level are item-specific and should be confirmed on the CoA/Spec Sheet.
Synthetic Utility
  • Functional group leverage (general for mPEG amide acetaldehyde)

    • Aldehyde terminus: enables formation of imines/Schiff bases with primary amines, oximes with aminooxy groups, and hydrazones with hydrazides; each linkage can be optionally reduced to a secondary amine for permanence.
    • Amide spacer: provides a chemically robust linkage between PEG and the reactive aldehyde-bearing arm; modulates steric and electronic properties.
    • PEG handle: enhances solubility in polar media, acts as a phase tag, and can facilitate purification of conjugates by SEC or precipitation techniques.
  • Representative transformations (literature/typical)

    • Reductive amination: mPEG–CHO + R–NH2 → mPEG–CH(=NR) + reduction → mPEG–CH2–NH–R.
    • Oxime ligation: mPEG–CHO + R–ONH2 → mPEG–CH=N–O–R (often high-yielding in water, mildly acidic, aniline-catalyzed).
    • Hydrazone formation: mPEG–CHO + R–NHNH2 → mPEG–CH=N–NH–R (may be reduced for stability).
    • Acetal formation/protection: temporary masking of the aldehyde as acetal using diols for multistep workflows.
  • Retrosynthetic value

    • Serves as a polymer-bound electrophile for appending PEG onto amine-bearing small molecules, polymers, or surfaces late in synthesis, improving aqueous compatibility without overhauling the core scaffold.
  • Practical notes

    • Control stoichiometry and concentration to manage viscosity and diffusion limits. For heterogeneous surfaces, longer reaction times and gentle mixing improve uniformity.
    • Analytical tracking via 1H NMR (model systems), IR (C=N band emergence), SEC/MALDI (for peptides), and colorimetric aldehyde assays (to quantify consumption).
Target Specificity
  • Not applicable to this product type.
  • Rationale: mPEG amide acetaldehyde is a synthetic polymer reagent and not a biological affinity reagent (e.g., antibody/ligand). It does not possess intrinsic target specificity beyond general chemoselectivity of its aldehyde group toward primary amines, aminooxy, and hydrazide functionalities.

Preguntas frecuentes

How should this product be stored?
Store at room temperature.
How is this product shipped?
This product ships under standard ambient conditions. No temperature-controlled packaging is required.
What documentation is provided?
Available product documentation, including Certificates of Analysis (COA), Safety Data Sheets (SDS), and specification sheets, is shown in the product document area. Document availability and access follow the current site policy.

¿Quieres que te enviemos un mensaje cuando tengamos descuentos disponibles?

Recordármelo más tarde

¡Gracias! Por favor, revisa tu bandeja de entrada de correo electrónico para confirmar.

¡Vaya! Las notificaciones están desactivadas.